Paul R. Gugliuzza in the Media

Law360 October 20, 2026

FTC Gender Care Suit Sparks Latest Judge-Shopping Debate

Professor Paul Gugliuzza explains how handpicking a judge in politically charged cases harms a fair and impartial judicial system.

Daily Journal October 14, 2026

Patent venue wars cool as Texas litigation shifts east

Professor Paul Gugliuzza points out that the Federal Circuit has granted a fraction of mandamus petitions challenging convenience-based transfer denials nationwide since 2022.

Law.com September 28, 2026

Short Shrift? Supreme Court Clerk Hiring Mostly Skips This Appeals Court

Professor Paul Gugliuzza recognizes how, in terms of hiring Supreme Court clerks, perceptions differ regarding clerks at the Federal Circuit and those at the D.C. Circuit, despite both having outstanding credentials.

PatentlyO September 22, 2026

The Federal Circuit Expands Its Jurisdiction Yet Again

Professor Paul Gugliuzza authors a guest post arguing the Federal Circuit wrongfully answered the jurisdictional question in Insulet v. EOFlow by holding the trade secret case arose under patent law.

Bloomberg Law September 2, 2026

A&O Shearman Brings on Patent Judge Alan Albright: Texas Brief

Professor Paul Gugliuzza shares why he believes Judge Alan Albright will have a positive impact on A&O Shearman's Austin office.

Daily Journal August 21, 2026

East Texas reclaims its patent crown

Professor Paul Gugliuzza says the Eastern District of Texas remains attractive to patent plaintiffs because of its experienced judges, fast schedules and trial-focused procedures, while defendants—particularly tech companies—have struggled to transfer cases out of the district.

Law360 August 17, 2026

Medtech Group Faults Fed. Circ. Trade Secret Timing Rule

An amicus brief filed by Professor Paul Gugliuzza urging the full Federal Circuit to revisit a decision that wiped out Insulet Corporation's trade secret win against EOFlow Co. Ltd. is highlighted.

Yale Journal on Regulation August 10, 2026

Law, Discretion, and Psychedelics

Professor Paul Gugliuzza applies Judge Henry Friendly's landmark lecture on legal discretion to the Ninth Circuit's AIMS decision, examining how the DEA's broad authority can both block and accelerate patient access to investigational psychedelic therapies.

Bloomberg Law July 22, 2026

A Cycling Icon Took on a Prolific Lawyer. The Dude Got Personal

In an article about a lawsuit against  a company owned by former cyclist Floyd Landis, Professor Paul Gugliuzza discusses the high-volume patent litigation model, noting that the potential profitability from a large number of small settlements.

Health Affairs July 9, 2026

The Supreme Court Protected Generics. Now FDA Must Navigate The Aftermath

Professor Paul Gugliuzza examines how the Supreme Court's Hikima decision protects generic drug manufactures and argues the FDA should clarify its "skinny-label" approval process to reduce patent disputes and preserve access to affordable medicines.

Law360 June 15, 2026

Newman’s Appeal Loss Shows Limits On Suspension Reviews

Professor Paul Gugliuzza analyzes aspects of a long-running dispute over a federal circuit judge's suspension and subsequent appeal.

Law.com June 8, 2026

Atlanta Civil Rights Attorney Cleared of Criminal Indictment Connected to Judge Shopping Investigation

Professor Paul Gugliuzza comments on the dismissal of a criminal indictment connected to an Alabama judge shopping investigation, noting reasons that the case appeared weak.